Molecular MRD status and outcome after transplantation in NPM1-mutated AML

Relapse remains the most common cause of treatment failure for patients with acute myeloid leukemia (AML) who undergo allogeneic stem cell transplantation (alloSCT), and carries a grave prognosis. Multiple studies have identified the presence of measurable residual disease (MRD) assessed by flow cyt...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Blood
Hoofdauteurs: Dillon, Richard, Hills, Robert, Freeman, Sylvie, Potter, Nicola, Jovanovic, Jelena, Ivey, Adam, Kanda, Anju Shankar, Runglall, Manohursingh, Foot, Nicola, Valganon, Mikel, Khwaja, Asim, Cavenagh, Jamie, Smith, Matthew, Ommen, Hans Beier, Overgaard, Ulrik Malthe, Dennis, Mike, Knapper, Steven, Kaur, Harpreet, Taussig, David, Mehta, Priyanka, Raj, Kavita, Novitzky-Basso, Igor, Nikolousis, Emmanouil, Danby, Robert, Krishnamurthy, Pramila, Hill, Kate, Finnegan, Damian, Alimam, Samah, Hurst, Erin, Johnson, Peter, Khan, Anjum, Salim, Rahuman, Craddock, Charles, Spearing, Ruth, Gilkes, Amanda, Gale, Rosemary, Burnett, Alan, Russell, Nigel H., Grimwade, David
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Hematology 2020
Onderwerpen:
Myeloid Neoplasia
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059484/
https://ncbi.nlm.nih.gov/pubmed/31932839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019002959
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items